Monday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Friday night in the US: The Dow Jones closed flat at 16,321, the NASDAQ finished down ten points at 4308 and the S&P 500 ended the day up five points at 1859.

This morning in London: The FTSE 100 is currently down 88 points at 6721.

FX and commodities: GBP/USD is down four pips at $1.6740, EUR/USD is down 21 pips at $1.3779 and USD/JPY is down 42 pips at ¥101.35. Brent crude is up 223 cents at $111.21 and gold is trading at $1347, up $21.85.

Stocks: Individual equity news will take a back seat to the bigger military issues in Ukraine, which are affecting all the major European indices this morning. Royal Bank of Scotland is looking to find partners with which to merge its Irish Ulster Bank, as it continues to asset-strip. Market sage Warren Buffet has carried on reducing his stake in Tesco, the UK’s largest food retailer. There’s more good news for AstraZeneca, as FDA approval has been given for its Bydureon pen.

The day ahead: Today’s G7 meeting will undoubtedly discuss Russia and Ukraine. The weekend’s HSBC final manufacturing figures have come out in line with expectations. Later in the morning we will also see the latest UK manufacturing purchasing manufacturers index, along with the US equivalent in the afternoon. ECB president Mario Draghi is also due to speak this afternoon. He was originally penciled in to discuss the economic and monetary environment in the EU, but he is also likely to cover the broader geo-political issues to the east.

All figures correct at 8.30am. All times London time.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Find articles by analysts

Een artikel zoeken

Form has failed to submit. Please contact IG directly.

  • Ik wens per e-mail informatie van IG Group bedrijven te ontvangen over handelsideeën en IG's producten en diensten.

Voor meer informatie over hoe wij uw gegevens mogelijk kunnen gebruiken, bekijkt u ons Privacy- en toegangsbeleid en onze privacy website.

CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen. 79% van de retailbeleggers lijdt verlies op de handel in CFD’s met deze aanbieder.
Het is belangrijk dat u goed begrijpt hoe CFD's werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
CFD’s zijn complexe instrumenten en brengen vanwege het hefboomeffect een hoog risico mee van snel oplopende verliezen.